Myomo, Inc. is a medical robotics company founded with the mission to enhance mobility for individuals suffering from neurological disorders and upper-limb paralysis. The company's vision centers on restoring independence and improving the quality of life for people affected by stroke, spinal cord injuries, and nerve damage. Myomo develops and markets advanced arm braces designed to restore function in paralyzed or weakened arms and hands, leveraging the principles of neuroplasticity to aid recovery and rehabilitation.
Notable figures associated with Myomo include leading experts in medical robotics and neurology. The company has attracted significant investment from healthcare-focused venture capital firms. Key achievements include FDA clearance for their MyoPro orthosis devices and successful clinical trials demonstrating improved patient outcomes. Myomo's impact is seen in the enhanced daily lives of stroke survivors and others with upper-limb impairments, as they regain the ability to perform essential tasks independently.
